Page last updated: 2024-10-22

alendronate and Cancer of Gastrointestinal Tract

alendronate has been researched along with Cancer of Gastrointestinal Tract in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Research Excerpts

ExcerptRelevanceReference
"The odds of being a case of oesophageal cancer, adjusted for smoking status, were significantly increased in women who had had one or more bisphosphonate prescriptions, odds ratio 1."1.38Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD). ( Molokhia, M; Schofield, PT; Seed, P; Wright, E, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wright, E1
Schofield, PT1
Seed, P1
Molokhia, M1

Other Studies

1 other study available for alendronate and Cancer of Gastrointestinal Tract

ArticleYear
Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Case-Control Studies; Databases, Factual; Dipho

2012